Related Experiment Videos
Host-parasite interactions in Taenia solium cysticercosis
A C White1, P Tato, J L Molinari
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
Summary
Neurocysticercosis, caused by Taenia solium, leads to neurological symptoms. Parasites evade immune responses, suggesting disease stems from parasite injury, impacting treatment strategies.
Area of Science:
- Neuroparasitology
- Immunology
- Neurology
Background:
- Human neurocysticercosis is caused by the larval form of Taenia solium, increasingly recognized as a cause of neurological symptoms.
- Taeniid parasites possess sophisticated mechanisms to evade host immune responses, including antibody and complement-mediated destruction.
- Mature metacestodes exhibit resistance to host defenses and may even manipulate the immune system for their benefit.
Purpose of the Study:
- To investigate the immune evasion strategies employed by Taenia solium metacestodes.
- To understand the host-parasite interactions in human neurocysticercosis.
- To hypothesize the primary cause of neurocysticercosis symptoms and its implications for treatment.
Main Methods:
- Review of existing literature on Taenia solium immunology and neurocysticercosis.
- Analysis of parasite mechanisms for evading host immune components like antibodies and complement.
- Examination of the relationship between inflammatory responses and parasite viability.
Main Results:
- Taenia solium metacestodes employ molecules like paramyosin, taeniaestatin, and sulfated polysaccharides to evade complement.
- Mature metacestodes are resistant to antibody-mediated killing and can potentially utilize host antibodies for nutrients.
- Parasite molecules may suppress cellular immunity by interfering with lymphocyte and macrophage functions.
Conclusions:
- Neurocysticercosis symptoms are likely caused by the host's inflammatory response to injured or dying parasites.
- The findings necessitate a re-evaluation of chemotherapy's role in managing neurocysticercosis.
- Current clinical trial evaluations may require revision due to the proposed disease mechanism.